CDXS.NASDAQCodexis, INC

Form 4: Opaleye Management Sells Over 1M CDXS Shares

Sentiment:

Insider Transaction Report


Opaleye Management Inc., a 10% owner and director of Codexis, Inc., reported the sale of over 1 million shares of common stock in multiple transactions.

Worse than expectedA 10% owner and director, Opaleye Management Inc., sold over 1 million shares of Codexis common stock.Significant insider selling can be perceived negatively by the market, suggesting that those with intimate knowledge of the company may believe the stock is fully valued or that future prospects are less favorable.

Summary

  • Opaleye Management Inc., a 10% owner and director of Codexis, Inc. (CDXS), reported the sale of 1,082,459 shares of common stock.
  • The sales occurred on November 12, 2025, through multiple transactions.
  • Shares were sold at weighted average prices of $1.9372 and $1.962.
  • The sales were executed by Opaleye, L.P. and a separately managed account, both managed by Opaleye Management Inc.
  • Following these transactions, Opaleye, L.P. indirectly beneficially owns 10,453,318 shares, and the Managed Account indirectly beneficially owns 196,012 shares.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by a 10% owner and director. While the reasons for selling are not disclosed, such transactions are often interpreted by the market as a lack of confidence or a belief that the stock is fully valued.

Negatives

  • A significant shareholder and director, Opaleye Management Inc., sold a substantial number of shares (over 1 million).
  • Insider selling can be interpreted as a lack of confidence in the company's future prospects by a knowledgeable party.

Risks

  • Potential negative market perception due to significant insider selling by a 10% owner and director.
  • Reduced alignment of interests between the reporting person and other shareholders as their stake decreases.

Future Outlook

NA

Industry Context

Insider selling by a significant shareholder can sometimes signal concerns about the company's performance relative to its industry peers, or a belief that the stock is overvalued compared to industry trends. However, without more context, it is difficult to draw definitive conclusions solely from this Form 4.

Related Party Transactions

  • The transactions involve Opaleye Management Inc., which is a 10% owner and director of Codexis, Inc.
  • The sales were conducted by entities managed by Opaleye Management Inc. (Opaleye, L.P. and a Managed Account).

Stakeholder Impact

  • Shareholders may view the significant insider selling as a negative signal, potentially leading to downward pressure on the stock price.
  • Management could face questions regarding the company's outlook if other insiders follow suit.

Key Dates

DateDescription
11/12/2025Date of earliest transaction for the sale of common stock.
11/14/2025Date the Form 4 was signed by James Silverman, President of Opaleye Management Inc.

Recommendation

sell

The substantial sale of over 1 million shares by a 10% owner and director, Opaleye Management Inc., signals a potential lack of confidence in Codexis's future performance or a belief that the stock is currently overvalued. While individual reasons for selling can vary, such a large insider divestment by a knowledgeable party often precedes periods of underperformance or indicates a ceiling on near-term growth, prompting a 'sell' recommendation for investors to consider reducing exposure.

Keywords

Codexis, CDXS, Opaleye Management, Insider Selling, Form 4, Beneficial Ownership, Stock Sale, Director Transaction, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.